Distalmotion

Positioning

Distalmotion is a Swiss surgical-robotics maker whose Dexter soft-tissue system targets ambulatory surgery centers, with a US commercial rollout underway. It raised $150M in November 2025 to accelerate US adoption. Revenue and deployment figures are undisclosed.

Latest signals

• 23 Oct 2026Distalmotion secured a term loan facility of up to $70 million from Perceptive Advisors to expand its U.S. ambulatory surgery center operations.startupticker.ch
• 18 Nov 2025Distalmotion’s DEXTER received FDA clearance for gynecologic use.The Robot Report
• 18 Nov 2025Distalmotion raised $150 million in Series G financing for DEXTER’s U.S. expansion.The Robot Report
• 18 Nov 2025Distalmotion’s DEXTER system has been used to treat almost 3,000 patients.The Robot Report
• 18 Nov 2025Distalmotion’s DEXTER surgical robot is commercially available in the U.S. and Europe.The Robot Report

6 signals name Distalmotion. Members see all of them, filtered by topic, source and date.

Facts, with sources

• 18 Nov 2025[object Object]Revenue band · The Robot Report
• 18 Nov 2025Series G financing for DEXTER's U.S. expansionFunding round · The Robot Report
• 18 Nov 2025Chas McKhann appointed executive chairman of the boardSenior hire · The Robot Report
• 18 Nov 2025DEXTER surgical robot commercially available in the U.S. and EuropeProduct launch · The Robot Report

6 facts on file. Members see all of them with the source link.

Scores, Robotics (of 10)

Traction: deployment, production, commercials, progress. Capability: technology, positioning, firepower, leverage.

Categories